NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 60.28

+6.3%

11:50 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (18)	1/19/2006 6:24:05 PM
From: Arthur Radley	Read Replies (1) of 507

Tuck, I don't give any credence to what this analyst said or is accused of saying since I didn't hear the interview. The key to this drug is the delivery system, so why would the FDA give approval to a drug and not include the key element? The NDA clearly included the inhaler and the powdered insulin...and both PFE and NKTR have clearly stated they are waiting the final approval that should come within days. The 90 day extension clearly indicated it was for review of additional data, etc...nothing about approving just part of the package. Plus, PFE and NKTR have openily discussed how they are building inventory in Indiana for the immediate launch of the product. With this being said...I think most of the price is already build into the shares and I took some off the table today. I still continue to hold a core position but pulled a sizeable gain because there is still the outside chance that labeling might be a bug-a-boo...and the CEO of PFE will have his hands full trying to explain that debacle.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next